TCM
CERE

Teza Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Teza Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,507
Closed -$571K – 787
2024
Q1 		$571K Buy
+13,507
New +$571K 0.08% 321